Related Experiment Video
Updated: Jun 18, 2026
08:27
A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
Published on: May 22, 2019
Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons
Jifang Tao1, Hao Wu, Yi Eve Sun
1Department of Molecular & Medical Pharmacology and Psychiatry & Behavioral Sciences, University of California, Los Angeles, CA, USA.
International Review of Neurobiology
|November 11, 2009
Summary
Mutations in methyl-CpG binding protein 2 (MECP2) cause Rett syndrome. Restoring MeCP2 function in the brain reversed Rett syndrome-like symptoms in mice, highlighting its critical role.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mutations in the methyl-CpG binding protein 2 (MECP2) gene are the primary cause of Rett syndrome (RTT).
- Studies in mouse models show that loss of functional MeCP2 in the central nervous system results in RTT-like symptoms.
- Restoration of MeCP2 expression can reverse these neurological deficits, indicating its crucial role in neuronal function.
Purpose of the Study:
- To elucidate the genome-wide function of MeCP2 in the context of Rett syndrome.
- To understand the molecular mechanisms underlying MeCP2's role in both transcriptional repression and activation.
- To explore potential therapeutic strategies for Rett syndrome by understanding MeCP2 restoration effects.
Main Methods:
- Utilizing advanced genomic technologies to analyze MeCP2 binding and its impact across the genome.
- Employing mouse genetics to study the effects of MeCP2 deficiency and restoration.
- Investigating the interaction of MeCP2 with other chromatin remodeling proteins.
Main Results:
- MeCP2 plays a complex role in gene regulation, acting as both a repressor and potentially an activator of transcription.
- Genome-wide analysis reveals specific targets and pathways affected by MeCP2 dysfunction.
- Evidence supports the reversibility of RTT-like phenotypes through MeCP2 restoration.
Conclusions:
- MeCP2 is essential for normal brain development and function, and its dysregulation leads to Rett syndrome.
- Understanding MeCP2's genome-wide targets and regulatory roles is key to deciphering RTT pathogenesis.
- Further research into MeCP2 function may pave the way for novel therapeutic interventions for Rett syndrome.
